Related Experiment Videos
Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus
Diabetes
|June 1, 1977
Summary
Newly diagnosed diabetics show nerve damage at diagnosis. Insulin treatment improved motor nerve function, while sulfonylurea treatment better controlled blood glucose but showed more autonomic dysfunction.
Area of Science:
- Neurology
- Endocrinology
- Diabetology
Background:
- Diabetic neuropathy is a common complication of diabetes mellitus.
- Early detection and management of nerve dysfunction are crucial for preventing long-term complications.
Purpose of the Study:
- To assess peripheral and autonomic nerve function in newly diagnosed male diabetics.
- To compare the effects of insulin versus sulfonylurea treatment on nerve function over six months.
Main Methods:
- Peripheral nerve function was assessed via motor-conduction velocity of the common peroneal nerve.
- Autonomic function was evaluated using electrocardiographic R-R-interval variation and the Valsalva maneuver.
- Patients were observed for six months with repeated assessments.
Main Results:
- Significant motor-conduction velocity impairment was observed at diagnosis in both treatment groups.
- Insulin-treated patients showed improvement in motor nerve function, unlike sulfonylurea-treated patients.
- Sulfonylurea treatment led to lower blood glucose levels but revealed greater autonomic dysfunction, including abnormal R-R-interval variation and Valsalva responses.
Conclusions:
- Peripheral and autonomic nerve abnormalities can be present at the diagnosis of diabetes.
- Insulin therapy may be more beneficial for improving peripheral nerve function compared to sulfonylurea.
- Further research is needed to understand the long-term implications of different treatment modalities on diabetic neuropathy.